Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis
Preety Bajwa, … , Ernst Lengyel, Hilary A. Kenny
Preety Bajwa, … , Ernst Lengyel, Hilary A. Kenny
Published February 16, 2023
Citation Information: JCI Insight. 2023;8(6):e163019. https://doi.org/10.1172/jci.insight.163019.
View: Text | PDF
Research Article Cell biology Oncology

Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis

  • Text
  • PDF
Abstract

Ovarian cancer (OvCa) preferentially metastasizes in association with mesothelial cell–lined surfaces. We sought to determine if mesothelial cells are required for OvCa metastasis and detect alterations in mesothelial cell gene expression and cytokine secretion upon interaction with OvCa cells. Using omental samples from patients with high-grade serous OvCa and mouse models with Wt1-driven GFP-expressing mesothelial cells, we validated the intratumoral localization of mesothelial cells during human and mouse OvCa omental metastasis. Removing mesothelial cells ex vivo from human and mouse omenta or in vivo using diphtheria toxin-mediated ablation in Msln-Cre mice significantly inhibited OvCa cell adhesion and colonization. Human ascites induced angiopoietin-like 4 (ANGPTL4) and stanniocalcin 1 (STC1) expression and secretion by mesothelial cells. Inhibition of STC1 or ANGPTL4 via RNAi obstructed OvCa cell-induced mesothelial cell to mesenchymal transition while inhibition of ANGPTL4 alone obstructed OvCa cell-induced mesothelial cell migration and glycolysis. Inhibition of mesothelial cell ANGPTL4 secretion via RNAi prevented mesothelial cell–induced monocyte migration, endothelial cell vessel formation, and OvCa cell adhesion, migration, and proliferation. In contrast, inhibition of mesothelial cell STC1 secretion via RNAi prevented mesothelial cell–induced endothelial cell vessel formation and OvCa cell adhesion, migration, proliferation, and invasion. Additionally, blocking ANPTL4 function with Abs reduced the ex vivo colonization of 3 different OvCa cell lines on human omental tissue explants and in vivo colonization of ID8p53–/–Brca2–/– cells on mouse omenta. These findings indicate that mesothelial cells are important to the initial stages of OvCa metastasis and that the crosstalk between mesothelial cells and the tumor microenvironment promotes OvCa metastasis through the secretion of ANGPTL4.

Authors

Preety Bajwa, Kasjusz Kordylewicz, Agnes Bilecz, Ricardo R. Lastra, Kristen Wroblewski, Yuval Rinkevich, Ernst Lengyel, Hilary A. Kenny

×

Figure 2

Depletion of mesothelial cells from the omentum inhibits OvCa cell adhesion and colonization.

Options: View larger image (or click on image) Download as PowerPoint
Depletion of mesothelial cells from the omentum inhibits OvCa cell adhes...
(A and B) Human ex vivo adhesion and colonization assays. Human omental tissue explants were digested with pronase before seeding of GFP-labeled Tyk-nu, OVCAR5, or Kuramochi OvCa cells, and the number of tumor cells that adhered/colonized on the omentum was quantified after 18 hours in A or 5 days in B. The cancer cells were digested off the omentum and counted using a fluorescent imaging cytometer. Data are represented as the mean ± SEM (n = 5). *P < 0.05 and **P < 0.01 by 1-way ANOVA. (C and D) Mouse ex vivo adhesion and colonization assays. C57Bl/6 mouse omental tissue explants were digested with pronase before seeding of GFP-labeled ID8p53–/–Brca2–/– cells, mouse OvCa cells, and the number of OvCa that adhered/colonized on the omentum were quantified at 18 hours in C or 5 days in D. The cancer cells were digested off the omentum and counted using a fluorescent imaging cytometer. Data are shown as the mean ± SEM (n = 8). ****P < 0.0001 using paired 2-tailed Student’s t test comparisons. (E) Experimental set-up for mouse models. MSLN-iDTR or the WT litter mates (control) were injected with DT or PBS for 3 consecutive days before transplantation with pchilli/luciferase-labeled ID8p53–/–Brca2–/– cells. (F and G) Mouse omental tissues were collected at 18 hours in F or 5 days in G after cancer cell injection digested, and a luciferase assay was performed. Data are represented as the mean ± SEM (n = 8), ****P < 0.0001 by 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts